ES2124884T3 - Nuevos derivados de prednisolona. - Google Patents

Nuevos derivados de prednisolona.

Info

Publication number
ES2124884T3
ES2124884T3 ES94913100T ES94913100T ES2124884T3 ES 2124884 T3 ES2124884 T3 ES 2124884T3 ES 94913100 T ES94913100 T ES 94913100T ES 94913100 T ES94913100 T ES 94913100T ES 2124884 T3 ES2124884 T3 ES 2124884T3
Authority
ES
Spain
Prior art keywords
pct
prednisolone
new derivatives
sec
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94913100T
Other languages
English (en)
Inventor
Beate Gutterer
Hermann Amschler
Dieter Flockerzi
Richard Riedel
Stefan Postius
Michael Stoeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Application granted granted Critical
Publication of ES2124884T3 publication Critical patent/ES2124884T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Abstract

LA INVENCION SE REFIERE A LOS EPIMEROS DEL COMPUESTO DE LA FORMULA (I) EN FORMA PURA, ASI COMO MEZCLAS DE ESTOS EPIMEROS EN CUALQUIERA DE SUS RELACIONES DE MEZCLA.
ES94913100T 1993-04-02 1994-03-31 Nuevos derivados de prednisolona. Expired - Lifetime ES2124884T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH102393 1993-04-02

Publications (1)

Publication Number Publication Date
ES2124884T3 true ES2124884T3 (es) 1999-02-16

Family

ID=4200650

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94913100T Expired - Lifetime ES2124884T3 (es) 1993-04-02 1994-03-31 Nuevos derivados de prednisolona.

Country Status (21)

Country Link
US (1) US5733901A (es)
EP (1) EP0701565B1 (es)
JP (1) JP3333210B2 (es)
KR (1) KR100330941B1 (es)
CN (1) CN1062869C (es)
AT (1) ATE172739T1 (es)
AU (1) AU683463B2 (es)
BG (1) BG62491B1 (es)
CZ (1) CZ287877B6 (es)
DE (1) DE59407183D1 (es)
DK (1) DK0701565T3 (es)
ES (1) ES2124884T3 (es)
FI (1) FI113543B (es)
HU (1) HU220868B1 (es)
NO (1) NO305990B1 (es)
NZ (1) NZ265054A (es)
PL (1) PL179489B1 (es)
RU (1) RU2132854C1 (es)
SK (1) SK281226B6 (es)
UA (1) UA45311C2 (es)
WO (1) WO1994022899A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19635498A1 (de) * 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
DE10055820C1 (de) * 2000-11-10 2002-07-25 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung eines Glucocorticoids
EA006231B1 (ru) * 2000-11-10 2005-10-27 Алтана Фарма Аг Способ получения 16,17-[(циклогексилметилен)бис(окси)]-11,21-дигидроксипрегна-1,4-диен-3,20-диона или его 21-изобутирата транскетализацией
EP2295062B1 (en) * 2002-08-30 2012-08-29 Nycomed GmbH The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
DE60323138D1 (de) * 2002-12-12 2008-10-02 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
JP2006527237A (ja) 2003-06-13 2006-11-30 アルタナ　ファルマ　アクチエンゲゼルシャフト ホルモテロールと及びシクレソニドの組合せ物
DE602004028497D1 (de) * 2003-09-15 2010-09-16 Nycomed Gmbh Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
JP2007533706A (ja) * 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
CA2579007A1 (en) * 2004-09-10 2006-03-16 Altana Pharma Ag Ciclesonide and syk inhibitor combination and methods of use thereof
CN100345864C (zh) * 2004-10-29 2007-10-31 天津药业研究院有限公司 一种治疗呼吸道疾病的甾体药物的制备方法及其中间体
RU2008100237A (ru) * 2005-06-14 2009-07-20 Джилид Сайэнс, Инк. (US) ОБЩИЕ ПРОЛЕКАРСТВЕННЫЕ ФОРМЫ СТЕРОИДОВ И β-АГОНИСТОВ (ВАРИАНТЫ), ВКЛЮЧАЮЩИЙ ИХ АЭРОЗОЛЬНЫЙ СОСТАВ (ВАРИАНТЫ) И СПОСОБ ПРЕДОТВРАЩЕНИЯ И/ИЛИ ЛЕЧЕНИЯ ЛЕГОЧНЫХ ВОСПАЛЕНИЙ И/ИЛИ БРОНХОСТЕНОЗА С ИХ ПОМОЩЬЮ
WO2007054974A2 (en) * 2005-09-28 2007-05-18 Arch Pharmalab Limited A green chemistry process for the preparation of pregnadiene esters
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
WO2008035066A2 (en) * 2006-09-19 2008-03-27 Cipla Limited Processes for the preparation of ciclesonide and its crystal form
WO2009112557A2 (en) * 2008-03-13 2009-09-17 Farmabios S.P.A. Process for the preparation of pregnane derivatives
ITMI20080645A1 (it) * 2008-04-11 2009-10-12 Ind Chimica Srl Procedimento per la preparazione di budesonide
EP2407476B1 (en) * 2009-03-09 2014-05-07 Mikasa Seiyaku Co,. Ltd. Steroid compound
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
CN103421075B (zh) * 2012-05-16 2017-07-28 上海特化医药科技有限公司 孕烷衍生物16,17‑缩醛(酮)的制备方法
CR20180594A (es) 2016-06-02 2019-07-29 Abbvie Inc Agonista del receptor de glucocorticoides e inmunoconjugados del mismo
RU2020117698A (ru) 2017-12-01 2022-01-04 Эббви Инк. Агонист глюкокортикоидного рецептора и его иммуноконъюгаты

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990401A (en) * 1958-06-18 1961-06-27 American Cyanamid Co 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids
GB1382614A (en) * 1972-01-10 1975-02-05 Squibb & Sons Inc Steroid compositions
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.

Also Published As

Publication number Publication date
BG62491B1 (bg) 1999-12-30
NO305990B1 (no) 1999-08-30
NZ265054A (en) 1997-08-22
FI954579A (fi) 1995-09-27
FI113543B (fi) 2004-05-14
EP0701565B1 (de) 1998-10-28
JPH08508278A (ja) 1996-09-03
PL311474A1 (en) 1996-02-19
AU683463B2 (en) 1997-11-13
CN1120339A (zh) 1996-04-10
EP0701565A1 (de) 1996-03-20
WO1994022899A1 (de) 1994-10-13
ATE172739T1 (de) 1998-11-15
CN1062869C (zh) 2001-03-07
PL179489B1 (pl) 2000-09-29
FI954579A0 (fi) 1995-09-27
UA45311C2 (uk) 2002-04-15
KR100330941B1 (ko) 2002-10-12
DE59407183D1 (de) 1998-12-03
RU2132854C1 (ru) 1999-07-10
HU9502819D0 (en) 1995-11-28
CZ252995A3 (en) 1996-01-17
BG100032A (bg) 1996-05-31
SK122395A3 (en) 1996-01-10
SK281226B6 (sk) 2001-01-18
US5733901A (en) 1998-03-31
NO953861L (no) 1995-09-29
NO953861D0 (no) 1995-09-29
JP3333210B2 (ja) 2002-10-15
CZ287877B6 (cs) 2001-03-14
HUT72594A (en) 1996-05-28
HU220868B1 (en) 2002-06-29
DK0701565T3 (da) 1999-07-12
AU6538194A (en) 1994-10-24

Similar Documents

Publication Publication Date Title
ES2124884T3 (es) Nuevos derivados de prednisolona.
TW285667B (es)
SG55184A1 (en) New imidazopyridines
DK41193D0 (da) Ionkanalaabnere
TR199801179T2 (xx) Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri.
HK1002017A1 (en) Lyospheres comprising gonadotropin
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
ZA949593B (en) N-substituted azabicycloheptane derivatives their preparation and use
AU7345391A (en) Derivative of beta-phenylisoserine, preparation and utilisation thereof
TW261614B (es)
TW251283B (es)
IL109398A0 (en) Benzo (F) quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU1067295A (en) Substituted aminoalkylaminopyridines
NO305116B1 (no) Fremgangsmate for fremstilling av C-substituerte dietylentriaminer
CA2159627A1 (en) Novel prednisolone derivatives

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 701565

Country of ref document: ES